Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRNA | Common Stock | Options Exercise | $0 | +703 | $0.00 | 703 | Apr 28, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRNA | Restricted Stock Units | Options Exercise | $0 | -703 | -100% | $0.00* | 0 | Apr 28, 2022 | Common Stock | 703 | $0.00 | Direct | F1, F2 |
transaction | MRNA | Stock Option (Right to Buy) | Award | $0 | +5.42K | $0.00 | 5.42K | Apr 28, 2022 | Common Stock | 5.42K | $142.52 | Direct | F3 |
Id | Content |
---|---|
F1 | Restricted stock units convert into common stock on a one-for-one basis. |
F2 | The shares subject to this restricted stock unit award vested in full on April 28, 2022. |
F3 | This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. |